Literature DB >> 9772317

Evidence of dengue virus infection in a german couple returning from hawaii

.   

Abstract

Dengue is an acute, mosquito-transmitted viral disease characterized by fever, arthralgia, myalgia, rash, nausea, and vomiting and caused by any of four different serotypes of the virus (DEN-1, DEN-2, DEN-3, and DEN-4).1 The disease is endemic in most tropical areas of the world and has been reported in international travelers returning from such areas.2 The incidence of epidemic and endemic dengue has increased substantially in the Americas since 1977, and various epidemics have occurred.1-4

Entities:  

Year:  1998        PMID: 9772317

Source DB:  PubMed          Journal:  J Travel Med        ISSN: 1195-1982            Impact factor:   8.490


  6 in total

1.  Spatially disaggregated disease transmission risk: land cover, land use and risk of dengue transmission on the island of Oahu.

Authors:  Sophie O Vanwambeke; Shannon N Bennett; Durrell D Kapan
Journal:  Trop Med Int Health       Date:  2010-11-14       Impact factor: 2.622

Review 2.  Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission.

Authors:  Louis Lambrechts; Thomas W Scott; Duane J Gubler
Journal:  PLoS Negl Trop Dis       Date:  2010-05-25

Review 3.  Lessons learned during dengue outbreaks in the United States, 2001-2011.

Authors:  Amesh A Adalja; Tara Kirk Sell; Nidhi Bouri; Crystal Franco
Journal:  Emerg Infect Dis       Date:  2012-04       Impact factor: 6.883

Review 4.  Transmission of infectious diseases during commercial air travel.

Authors:  Alexandra Mangili; Mark A Gendreau
Journal:  Lancet       Date:  2005 Mar 12-18       Impact factor: 79.321

Review 5.  Dengue in the United States of America: a worsening scenario?

Authors:  Germán Añez; Maria Rios
Journal:  Biomed Res Int       Date:  2013-06-20       Impact factor: 3.411

6.  Dengue fever in travellers: A challenge for European physicians.

Authors:  Uditha Bulugahapitiya; Sajith Siyambalapitiya; Suranjith L Seneviratne; Devaka J S Fernando
Journal:  Eur J Intern Med       Date:  2007-05       Impact factor: 4.487

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.